摘要
全世界大量的资源被投入到各种癌症的预防、诊断和治疗中。治愈癌症需要精确得诊断和严谨的治疗方案。传统的全身给药方法在不对正常组织产生毒性的前提下,通常不能完全去除有活性的癌细胞。因此,高效给药系统的开发在医疗保健中是很重要的。而且,分子成像在疾病治疗中发挥着越来越重要的革命性作用。分子成像和靶向给药方法的联合使用被称为影像引导给药(IGDD)的相关新领域提供了独特的机会。单光子发射计算机体层摄影(SPECT)是临床上应用最广泛的核成像方法,越来越多地被用于引导靶向治疗。材料科学的创新促进了基于聚合物、脂质体、胶束、树状大分子、微粒、纳米粒子等的高效药物载体的发展。这些运用了SPECT成像技术的药物载体的高效利用具有进行个性化治疗,减少传统治疗过程的侵袭力和快速监视疗效的潜力。SPECT-IGDD不仅用于治疗癌症,也能用于其他疾病。这里,我们简要回顾了SPECT-IGDD方法的最新进展,讨论了该领域的发展前景和挑战。
关键词: 癌症,化疗,影像引导给药,分子成像,单光子发射计算机体层摄影,治疗诊断学。
Current Drug Targets
Title:Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature
Volume: 16 Issue: 6
Author(s): Rubel Chakravarty, Hao Hong and Weibo Cai
Affiliation:
关键词: 癌症,化疗,影像引导给药,分子成像,单光子发射计算机体层摄影,治疗诊断学。
摘要: Tremendous resources are being invested all over the world for prevention, diagnosis, and treatment of various types of cancer. Successful cancer management depends on accurate diagnosis of the disease along with precise therapeutic protocol. The conventional systemic drug delivery approaches generally cannot completely remove the competent cancer cells without surpassing the toxicity limits to normal tissues. Therefore, development of efficient drug delivery systems holds prime importance in medicine and healthcare. Also, molecular imaging can play an increasingly important and revolutionizing role in disease management. Synergistic use of molecular imaging and targeted drug delivery approaches provides unique opportunities in a relatively new area called ‘image-guided drug delivery’ (IGDD). Single-photon emission computed tomography (SPECT) is the most widely used nuclear imaging modality in clinical context and is increasingly being used to guide targeted therapeutics. The innovations in material science have fueled the development of efficient drug carriers based on, polymers, liposomes, micelles, dendrimers, microparticles, nanoparticles, etc. Efficient utilization of these drug carriers along with SPECT imaging technology have the potential to transform patient care by personalizing therapy to the individual patient, lessening the invasiveness of conventional treatment procedures and rapidly monitoring the therapeutic efficacy. SPECT-IGDD is not only effective for the treatment of cancer but might also find utility in the management of several other diseases. Herein, we provide a concise overview of the latest advances in SPECT-IGDD procedures and discuss the challenges and opportunities for advancement of the field.
Export Options
About this article
Cite this article as:
Rubel Chakravarty, Hao Hong and Weibo Cai , Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature, Current Drug Targets 2015; 16 (6) . https://dx.doi.org/10.2174/1389450115666140902125657
DOI https://dx.doi.org/10.2174/1389450115666140902125657 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Engineered Liposomes for Drug Delivery and Biomedical Imaging
Recent Patents on Nanomedicine Rock1 & 2 Perform Overlapping and Unique Roles in Angiogenesis and Angiosarcoma Tumor Progression
Current Molecular Medicine Application of Recombinant and Non-Recombinant Peptides in the Determination of Tumor Response to Cancer Therapy
Current Pharmaceutical Biotechnology Peptide-based Self-assembly: Design, Bioactive Properties, and Its Applications
Current Pharmaceutical Design Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line
Current Pharmaceutical Biotechnology Design and Synthesis of Novel Thiosemicarbazones as Potent Anti-breast Cancer Agents
Letters in Drug Design & Discovery The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine A Simple Protein Extraction Method for Proteomic Analysis of Diverse Biological Specimens
Current Proteomics In Situ Gene Therapy for Prostate Cancer
Current Gene Therapy A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development
Current Topics in Medicinal Chemistry Aptamers: Selection, Modification and Application to Nervous System Diseases
Current Medicinal Chemistry Nucleic Acids as Therapeutic Agents
Current Topics in Medicinal Chemistry Recent Advances in Formation, Properties, and Applications of Polymersomes
Current Pharmaceutical Design Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration
Current Pharmaceutical Design Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Current Pharmaceutical Design Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer
Current Protein & Peptide Science The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets MicroRNAs in Cancer Gene Therapy: Another Look
Current Cancer Therapy Reviews Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy
Current Pharmaceutical Design